| Cancer |
Tissue Repository For The Collection of Hematologic Samples |
Suzanne Lentzsch, MD |
| Cancer |
Identification of Targets for Cancer Treatment |
Andrea Califano, PhD |
| Cancer |
Clinical Trial Screening Tool to Address Cancer Health Disparities |
Katherine Crew, MD |
| Cancer |
Study of Ipilimumab, Cabozantinib, and Nivolumab in Rare Genitourinary Cancers (ICONIC) |
Mark Stein, MD |
| Cancer |
Study of IDE196 in Patients with Solid Tumors |
Alexander Wei, MD |
| Cancer |
Safety Study of PBCAR0191 in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma and r/r B-cell Acute Lymphoblastic Leukemia |
Ran Reshef, MD |
| Cancer |
Study of Safety and Tolerability of BCA101 Alone and in Combination With Pembrolizumab in Patients With EGFR-driven Advanced Solid Tumors |
Catherine Shu, MD |
| Cancer |
Study of IMC-F106C Alone and in Combination With Checkpoint Inhibitors in Participants with Advanced Cancers |
Benjamin Izar, MD |
| Cancer |
Study of Peposertib With Avelumab and Radiation Therapy for Advanced/Metastatic Solid Tumors and Hepatobiliary Malignancies |
Susan Bates, MD |
| Cancer |
A Study of BMS-986340 Alone and in Combination With Nivolumab in Participants With Advanced Solid Tumors |
Ryan Moy, MD |
| Cancer |
Study of Investigational Drug (RP-6306) in Patients with Advanced Cancer |
Ryan Moy, MD |
| Cancer |
Study of Isatuximab in Patients with Monoclonal Gammopathy of Renal Significance (MGRS) |
Divaya Bhutani, MD |
| Cancer |
Study of IDE397 in Patients with Advanced Solid Tumors |
Benjamin Herzberg, MD |
| Cancer |
Study of CS5001 in Patients with Advanced Solid Tumors |
Hua-Jay Cherng, MD |
| Cancer |
Study of ASP3082 in Patients with Advanced Cancer with a KRAS G12D Mutation |
Benjamin Herzberg, MD |
| Cancer |
Study of STK-012 Alone or in Combination with Pembrolizumab (KEYTRUDA) in Patients with Advanced Solid Tumors |
Benjamin Izar, MD |
| Cancer |
Study of 68Ga-FAP-2286 and 177Lu-FAP-2286 in Patients with Advanced Cancer |
Ryan Moy, MD |
| Cancer |
Study of XL092 Alone or in Combination with Anticancer Therapy in Patients with Unresectable orMetastatic Solid Tumors |
Karie D. Runcie, MD |
| Cancer |
Study of MRT-2359 in Patients with Solid Tumors |
Benjamin Herzberg, MD |
| Cancer |
Study of RMC-6236 in Patients with Solid Tumors with a KRAS Mutation |
Benjamin Herzberg, MD |
| Cancer |
Study of BGB-16673 in Patients with Leukemia or Lymphoma |
Nicole Lamanna, MD |
| Cancer |
Cooling and Compression to Prevent Nerve Damage During Chemotherapy |
Melissa Accordino, MD |
| Cancer |
Study of T Plex in Patients with Advanced or Metastatic Solid Tumors |
Brian Henick, MD |
| Cancer |
Study of ZEN003694 (ZEN-3694) in Combination with Capecitabine in Patients with Solid Tumors |
Ryan Moy, MD |
| Cancer |
Study of HRO761 Alone or in Combination with Tislelizumab or Irinotecan in Patients with Solid Tumors |
Edmond Chan, MD |
| Cancer |
Study of DB-1311 in Patients with Solid Tumors |
Brian Henick, MD |
| Cancer |
Study of PRT3789 in Patients with Advanced or Metastatic Solid Tumors with a SMARCA4 Mutation |
Benjamin Herzberg, MD |
| Cancer |
Study of RMC-6291 and RMC 6236 in Patients with Solid Tumors |
Benjamin Herzberg, MD |
| Cancer |
Study of RP-1664 in Patients with Solid Tumors |
Benjamin Herzberg, MD |
| Cancer |
Study of SGN-B6A in Advanced Solid Tumors |
Benjamin Herzberg, MD |
| Breast Cancer |
Study to Predict Your Therapeutic Response (I-SPY 2 Trial) |
Meghna Trivedi, MD |
| Breast Cancer |
Study Comparing Survival of Patients Monitored with Serum Tumor Marker Directed Disease Versus Usual Care in Metastatic Breast Cancer |
Melissa Accordino, MD |
| Breast Cancer |
Addinex-Opioid Dispenser for Post-Op Pain in Cancer Patients |
Dawn Hershman, MD |
| Breast Cancer |
Study of Symptom Monitoring using Young, Empowered & Strong (YES) Web Portal for Breast Cancer Survivors |
Dawn Hershman, MD |
| Breast Cancer |
Intervention to Improve Medication Scheduling for Patients with Breast Cancer |
Dawn Hershman, MD |
| Breast Cancer |
Study of RLY-2608 in Patients with Breast Cancer |
Julia McGuinness, MD |
| Breast Cancer |
Study of GLSI-100 in Female Patients with Breast Cancer |
Julia McGuinness, MD |
| Breast Cancer |
Study of Breast Cancer in Black Women |
Lauren Houghton, PhD |
| Breast Cancer |
Study of Radiotherapy in Patients with Low-Risk HER2-Positive Breast Cancer (HERO*) |
Eileen Connolly, MD, PhD |
| Breast Cancer |
Improving Medication Barriers Among Patients with Metastatic Breast Cancer |
Claire Sathe, MD |
| Multiple Myeloma |
Study of Isatuximab in Patients with Multiple Myeloma or Lymphoma who are Recovering from Stem Cell Transplant |
Divaya Bhutani, MD |
| Multiple Myeloma |
Study of Daratumumab in Addition to Chemotherapy for Patients with Smoldering Multiple Myeloma (SMM) |
Rajshekhar Chakraborty, MD |
| Multiple Myeloma |
Study of Venetoclax in Combination with Dexamethasone in Patients with Light Chain Amyloidosis |
Rajshekhar Chakraborty, MD |
| Multiple Myeloma |
Study of Teclistamab In Patients with Multiple Myeloma |
Divaya Bhutani, MD |
| Multiple Myeloma |
Study of REGN5458 in Patients with Multiple Myeloma |
Rajshekhar Chakraborty, MD |
| Multiple Myeloma |
Study of BMS-986393 in Patients with Multiple Myeloma (MM) |
Divaya Bhutani, MD |
| Multiple Myeloma |
Study of Linvoseltamab in Patients with Multiple Myeloma (NDMM) |
Rajshekhar Chakraborty, MD |
| Skin Cancer |
Study of IMC-F106C in Combination with Nivolumab in Patients with Advanced Melanoma |
Benjamin Izar, MD |
| Liver Cancer |
Study of Cancer Immunotherapy (CIT) Before Surgery in Patients with Liver Cancer |
Ryan Moy, MD |
| Liver Cancer |
Liquid biopsy and radiomics for liver cancer surveillance |
Elizabeth Verna, MD |
| Lymphoma |
Study of Tazemetostat or Placebo with Lenalidomide plus Rituximab in Subjects With Relapsed/Refractory Follicular Lymphoma |
Jennifer Amengual, MD |
| Lymphoma |
Study of Isatuximab in Patients with Multiple Myeloma or Lymphoma who are Recovering from Stem Cell Transplant |
Divaya Bhutani, MD |
| Lymphoma |
Study of CC-486 (Oral Azacitidine) Alone or in Combination with Chemo in Participants with Diffuse Large B Cell Lymphoma (DLBCL) (Ages 75+) |
Jennifer Amengual, MD |
| Lymphoma |
Study of Duvelisib or Azacitidine in Addition to Chemotherapy in Patients with Peripheral T-Cell Lymphoma (PTCL) |
Jennifer Amengual, MD |
| Lymphoma |
Study of Lenalidomide in Combination with Chemotherapy in Patients with HTLV-Associated Adult T-Cell Leukemia-Lymphoma (ATLL) |
Jennifer Amengual, MD |
| Lymphoma |
Study of Tazemetostat in Combination with Belinostat in Patients with Relapsed or Refractory Lymphoma |
Jennifer Amengual, MD |
| Lymphoma |
Study of ONO-4685 in Patients with T-Cell Lymphoma |
Barbara Pro, MD |
| Lymphoma |
Study of Axi-cel vs. Chemotherapy in Patients with High-Risk Large B-Cell Lymphoma |
Ran Reshef, MD |
| Lymphoma |
Study of Relatlimab and Nivolumab in Patients Under 30 Years Old with Classical Hodgkin Lymphoma (cHL) and Non-Hodgkin Lymphoma (NHL) |
Nobuko Hijiya, MD |
| Lymphoma |
Study of KITE-363 vs. KITE-753 in Patients with B-cell Lymphoma |
Ran Reshef, MD |
| Lymphoma |
Study of Tazemetostat or Zanubrutinib for Patients with Large B-Cell Lymphoma (LBCL) |
Jennifer Amengual, MD |
| Lymphoma |
Study of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma |
Barbara Pro, MD |
| Lymphoma |
Treatment After CAR T-Cell Therapy for Patients with Diffuse Large B-cell Lymphoma (DLBCL) |
Hua-Jay Cherng, MD |
| Lymphoma |
PhasED-seq in Patients with Diffuse Large B-cell Lymphoma (DLBCL) |
Hua-Jay Cherng, MD |
| Lung Cancer |
Study of Therapies in Participants with Resectable (removable) and Untreated Non-Small Cell Lung Cancer (NSCLC) |
Catherine Shu, MD |
| Lung Cancer |
ApricityCare: Smartphone App Study for Patients with Non-Small Cell Lung Cancer (NSCLC) |
Brian Henick, MD |
| Lung Cancer |
Study of JNJ-86974680 Alone or in Combination with Cetrelimab and Radiotherapy in Patients with Non-Small Cell Lung Cancer (NSCLC) |
Brian Henick, MD |
| Lung Cancer |
Study of Osimertinib in Patients with Non-Small Cell Lung Cancer (NSCLC) |
Catherine Shu, MD |
| Lung Cancer |
Study of Durvalumab in Patients with Non-Small Cell Lung Cancer (NSCLC) |
Benjamin Herzberg, MD |
| Gynecologic Cancer |
Study of REGN4018 Alone or in Combination with Cemiplimab in Patients with Ovarian Cancer |
June Hou, MD |
| Gynecologic Cancer |
Comparing Investigational Surgery to Laparotomy After Chemotherapy in Women with Epithelial Ovarian Cancer (EOC) |
Jason Wright, MD |
| Gynecologic Cancer |
Study of TransCon IL-2 / vs. TransCon TLR7/8 Agonist in Patients with Gynecologic Cancer |
June Hou, MD |
| Gynecologic Cancer |
Study of ACR-368 (Prexasertib) in Patients with Ovarian Carcinoma, Endometrial Adenocarcinoma, or Urothelial Carcinoma |
June Hou, MD |
| Pancreatic Cancer |
The Cancer of the Pancreas Screening-5 Study (CAPS5 Study) |
Fay Kastrinos, MD |
| Pancreatic Cancer |
Chemo4METPANC: Combination of Chemotherapy, Motixafortide, and Cemiplimab in Patients with Pancreatic Cancer |
Gulam Manji, MD, PhD |
| Pancreatic Cancer |
Study of Bethanechol in Combination with Chemotherapy for Patients with Pancreatic Cancer |
Susan Bates, MD |
| Pancreatic Cancer |
Study of Zimberelimab in Patients with Advanced Pancreatic Cancer who are Eligible for Surgery |
Gulam Manji, MD, PhD |
| Pancreatic Cancer |
Study of Autogene Cevumeran & Atezolizumab Alone or in Combination with mFOLFIRINOX in Patients with Resected Pancreatic Cancer (PDAC) |
Gulam Manji, MD, PhD |
| Pancreatic Cancer |
Study of ASP2138 in Patients with Stomach or Pancreatic Cancer |
Ryan Moy, MD |
| Pancreatic Cancer |
Study of Quemliclustat and Chemotherapy vs Placebo and Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PRISM-1) |
Gulam Manji, MD, PhD |
| Leukemia |
Study of TSC 100 & TSC 101 in Patients with Leukemia Undergoing Haploidentical Allogeneic Blood Stem Cell Transplantation (HCT) |
Ran Reshef, MD |
| Leukemia |
Study of Polatuzumab Vedotin in Combination with Chemotherapy in Subjectswith Richter's Transformation |
Andrew Lipsky, MD |
| Leukemia |
Study of BLU-263 in Patients with Indolent Systemic Mastocytosis (ISM) or Monoclonal Mast Cell Activation Syndrome (mMCAS) |
Joseph Jurcic, MD |
| Leukemia |
Study of Drug - DSP-5336 in Patients with Leukemia |
Joseph Jurcic, MD |
| Leukemia |
Study of SEA-CD70 in Patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) |
Joseph Jurcic, MD |
| Leukemia |
Pediatric Acute Leukemia (PedAL) Screening Trial - Developing New Therapies for Relapsed Leukemias (Children and Young Adults) |
Nobuko Hijiya, MD |
| Leukemia |
Bone Marrow Transplant (BMT) Study in Patients with Acute Leukemia |
Markus Mapara, MD |
| Bladder Cancer |
Study of Gemcitabine and Docetaxel Treatment in Patients with Bladder Cancer (BRIDGE) |
Andrew Lenis, MD |
| Gastrointestinal |
Study of ASP2138 in Patients with Stomach or Pancreatic Cancer |
Ryan Moy, MD |
| Gastrointestinal |
The Janus Rectal Cancer Trial |
Yoanna Pumpalova, MD |
| Gastrointestinal |
Study of Defactinib & Avutometinib in Patients with Stomach Cancer |
Ryan Moy, MD |
| Gastrointestinal |
Study of LBL-007 & Tislelizumab in Patients with Colon Cancer |
Yoanna Pumpalova, MD |
| Prostate Cancer |
IRONMAN: International Registry for Men with Advanced Prostate Cancer |
Mark Stein, MD |
| Prostate Cancer |
Study of REGN5678 (Anti-PSMAxCD28) With Cemiplimab (Anti-PD-1) in Patients With Metastatic Castration-resistant Prostate Cancer |
Mark Stein, MD |
| Prostate Cancer |
Study of CC-94676 in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC) |
Karie D. Runcie, MD |
| Prostate Cancer |
Study of JNJ-78278343 in Patients with Advanced Prostate Cancer |
Mark Stein, MD |
| Prostate Cancer |
Study of Whole-Food Plant-Based Diet (WFPBD) to Control Weight in Overweight/Obese Men with Prostate Cancer |
Mark Stein, MD |
| Prostate Cancer |
Study of JNJ-87189401 in Combination with JNJ 78278343 in Patients with Prostate Cancer |
Mark Stein, MD |
| Prostate Cancer |
Study of Apalutamide Alone or in Combination with ADT in Patients with Metastatic Castration-Sensitive Prostate Cancer (mCSPC) |
Karie D. Runcie, MD |
| Prostate Cancer |
Study of ONC-392 in Combination with PLUVICTO in Male Patients with Prostate Cancer |
Mark Stein, MD |
| Kidney Cancer |
Study of Spartalizumab and Canakinumab Prior to Radical Nephrectomy in Patients with Localized Clear Cell Renal Cell Carcinoma |
Karie D. Runcie, MD |
| Kidney Cancer |
Cyto-KIK Trial: CYTO Reductive Surgery in Kidney Cancer Plus Immunotherapy and Targeted Kinase Inhibition |
Mark Stein, MD |
| Kidney Cancer |
Study of XmAb819 in Patients with Clear Cell Renal Cell Carcinoma |
Karie D. Runcie, MD |
| Sarcoma |
A Study of AL102 in Patients With Progressing Desmoid Tumors (RINGSIDE) |
Prabhjot Mundi, MD |
| Sarcoma |
Study of AGEN1181 Alone or in Combination with Balstilimab in Patients with Advanced Sarcoma |
Brian Henick, MD |
| Brain Cancer |
Study of Chemotherapy Drug, Lomustine, in Addition to Temozolomide in Patients with Glioblastoma (GBM) |
Fabio Iwamoto, MD |
| Brain Cancer |
Study of Tirabrutinib in Patients with Primary Central Nervous System Lymphoma (PCNSL) |
Fabio Iwamoto, MD |
| Brain Cancer |
Study of ONC201 After Radiation in Patients with Glioma |
Aya Haggiagi, MD |
| Brain Cancer |
Study of PF-07799544 in Patients with Solid Brain Tumors |
Aya Haggiagi, MD |
| Brain Cancer |
Study of Radiosurgery & Nivolumab Alone or in Combination with Ipilimumab in Patients with Meningioma |
Aya Haggiagi, MD |
| Brain Cancer |
Study of Sonocloud 9 in Patients with Glioblastoma (GBM) |
Brian Gill, MD |
| Brain Cancer |
Study of Lutathera in Patients with Glioblastoma (GB) |
Mikhail Doubrovin, MD |
| Brain Cancer |
Study of Eflornithine & Temozolomide in Patients with Glioblastoma Multiforme (GBM) |
Maria Diaz Ordonez, MD |
| Brain Cancer |
Study of AZD9574 in Patients with Brain Cancer |
Maria Diaz Ordonez, MD |
| Brain Tumors |
Study of Chemotherapy Drug, Lomustine, in Addition to Temozolomide in Patients with Glioblastoma (GBM) |
Fabio Iwamoto, MD |
| Melanoma |
Study of DYP688 in Patients with Melanoma |
Alexander Wei, MD |
| Healthy Volunteers |
Columbia University Biobank |
Muredach Reilly, MD |
| Brain Tumors |
Study of Tirabrutinib in Patients with Primary Central Nervous System Lymphoma (PCNSL) |
Fabio Iwamoto, MD |
| Melanoma |
Study of Fianlimab and Cemiplimab vs. Pembrolizumab in Patients with Resected High-Risk Melanoma |
Benjamin Izar, MD |
| Childhood Leukemia |
Pediatric Acute Leukemia (PedAL) Screening Trial - Developing New Therapies for Relapsed Leukemias (Children and Young Adults) |
Nobuko Hijiya, MD |
| Healthy Volunteers |
Study of Breast Cancer in Black Women - Healthy Controls |
Lauren Houghton, PhD |
| Cancer |
Study of Relatlimab and Nivolumab in Patients Under 30 Years Old with Classical Hodgkin Lymphoma (cHL) and Non-Hodgkin Lymphoma (NHL) |
Nobuko Hijiya, MD |
| Brain Tumors |
Study of PF-07799544 in Patients with Solid Brain Tumors |
Aya Haggiagi, MD |
| Heart Disease |
The DREAM Sleep Health Clinical Trial |
Nour Makarem, PhD |
| Brain Tumors |
Study of Sonocloud 9 in Patients with Glioblastoma (GBM) |
Brian Gill, MD |
| Brain Tumors |
Study of Eflornithine & Temozolomide in Patients with Glioblastoma Multiforme (GBM) |
Maria Diaz Ordonez, MD |
| Brain Tumors |
Study of AZD9574 in Patients with Brain Cancer |
Maria Diaz Ordonez, MD |
| Diabetes |
Temporary Insulin Resistance |
Joshua Cook, MD, PhD |
| Healthy Volunteers |
Temporary Insulin Resistance |
Joshua Cook, MD, PhD |
| Obesity |
Temporary Insulin Resistance |
Joshua Cook, MD, PhD |
